OSAHS患者经羧甲司坦联合氨茶碱治疗的疗效及临床应用价值  

The Therapeutic Efficacy and Clinical Application Value of Combining Carbocisteine with Aminophylline in Treating Patients with OSAHS

作　　者：王慧 苑小倩 梁耀升 WANG Hui;YUAN Xiaoqian;LIANG Yaosheng(First People′s Hospital of Zhoukou,Henan Zhoukou 466700,China)

机构地区：[1]周口市第一人民医院,河南周口466700

出　　处：《中国药物评价》2025年第1期68-72,共5页Chinese Journal of Drug Evaluation

摘　　要：目的:观察羧甲司坦联合氨茶碱对阻塞性睡眠呼吸暂停低通气综合征(OSAHS)患者睡眠质量及血清氧化应激指标的影响。方法:选取2021年1月至2023年5月本院收治的100例OSAHS患者为研究对象,采用奇偶数分组法分为对照组50例、联合组50例。对照组予以氨茶碱治疗,联合组予以羧甲司坦联合氨茶碱治疗。统计对比两组临床疗效及治疗前后呼吸调节指标、睡眠状态[睡眠转换次数、Epworth睡眠(ESS)评分、呼吸暂停低通气指数(AHI)、动脉血氧饱和度(SaO 2)]、氧化应激[8-羟基脱氧鸟苷(8-OHG)、氧化型低密度脂蛋白(ox-LDL)、超氧化物歧化酶(SOD)、丙二醛(MDA)]、炎症因子[白细胞介素-6(IL-6)、超敏C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)]。结果:联合组总有效率为92.00%,高于对照组的76.00%,差异有统计学意义(P<0.05);治疗后,联合组呼吸暂停低通气次数、最长呼吸暂停时间、最长呼吸低通气时间低于对照组,差异有统计学意义(P<0.05);治疗后,联合组睡眠转换次数、ESS评分、AHI分别为(96.32±26.31)次、(6.52±1.85)分、(9.02±2.03)次/h,均低于对照组的(158.94±32.98)次、(9.54±2.18)分、(13.57±3.52)次/h,且SaO 2(96.85±18.83%)高于对照组(88.20±19.41%),差异有统计学意义(P<0.05);联合组治疗后血清8-OHG、ox-LDL、MDA水平低于对照组,SOD水平高于对照组,差异有统计学意义(P<0.05);联合组治疗后血清IL-6、hs-CRP、TNF-α水平低于对照组,差异有统计学意义(P<0.05)。结论:羧甲司坦联合氨茶碱治疗OSAHS的疗效确切,可改善呼吸调节功能、睡眠质量,抑制炎症-氧化应激反应。Objective:To observe the effects of carboxymesteine combined with aminophylline on sleep quality and serum oxidative stress indexes in patients with obstructive sleep apnea hypopnea syndrome(OSAHS).Methods:A total of 100 OSAHS patients admitted to our hospital from January 2021 to May 2023 were selected as the study objects,and were divided into single group(50 cases)and combined group(50 cases)by odd-even grouping method.The single group was treated with aminophylline,and the combined group was treated with carboxymesteine combined with aminophylline.The clinical efficacy and respiratory regulation indexes,sleep status[Number of sleep transitions,Epworth sleep(ESS)score,apnea hypoventilation index(AHI),arterial oxygen saturation(SaO2)].,oxidative stress[8-hydroxydeoxyguanosine(8-OHG),oxidized low-density lipoprotein(ox-LDL),superoxide dismutase(SOD),malondialdehyde(MDA)],and inflammatory factors[Interleukin-6(IL-6),hypersensitive C-reactive protein(hs-CRP),tumor necrosis factor-α(TNF-α)]before and after treatment were statistically compared between the two groups.Results:The total effective rate of the combined group was 92.00%,which was higher than that of the single group(76.00%),and the difference was statistically significant(P<0.05).After treatment,the number of apnea-hypopnea events,the longest apnea time,and the longest hypopnea time in the combined group were lower than those in the single group,and the differences were statistically significant(P<0.05).After treatment,the number of sleep transitions,ESS scores,and AHI in the combined group were(96.32±26.31)times,(6.52±1.85)scores,and(9.02±2.03)times/h,respectively,which were lower than those in the single group(158.94±32.98)times,(9.54±2.18)scores,and(13.57±3.52)times/h,and SaO2(96.85±18.83%)was higher than that in the single group(88.20±19.41%),and the differences were statistically significant(P<0.05).The levels of serum 8-OHG,ox-LDL,and MDA in the combined group were lower than those in the single group,and the level of SOD was higher than

关 键 词：阻塞性睡眠呼吸暂停低通气综合征 羧甲司坦 氨茶碱 睡眠质量 氧化应激 

分 类 号：R974[医药卫生—药品]